#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pleural mesothelioma malignant Hereditary spastic paraplegia Hypergammaglobulinaemia benign monoclonal Myotonic dystrophy Chondrodystrophy Spinal cord injury cervical Hepatitis B Neurofibroma KBG syndrome Cutaneous lupus erythematosus Kearns-Sayre syndrome Epstein-Barr virus infection Glomerulonephritis minimal lesion Progressive multifocal leukoencephalopathy Brain abscess More trials…

    Learn about Rare Diseases

    Testicular leiomyosarcoma – Diagnostics Waldenstrom’s macroglobulinaemia – Basic Information Netherton’s syndrome – Life with Disease Nodal marginal zone B-cell lymphoma – Treatment Mucopolysaccharidosis I Myxofibrosarcoma – Trials in Disease Antithrombin III deficiency Loeys-Dietz syndrome – Basic Information Wiskott-Aldrich syndrome – Life with Disease Rett syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    POLYSORBATE 80 Deferoxamine Mesilate Bicalutamide Fluoxetine Anidulafungin Tinlarebant Proline Dcc-3116 Erythromycin Ethanol, Anhydrous Olanzapine ZINC Crizanlizumab Salmeterol Xinafoate Azd2693 Sodium Quavonlimab Montelukast Azetukalner Specific Nucleic Acid Sna-Ebv Insulin Human (Rdna) More therapies…

    Learn about Your Condition

    Staphylococcal infection Myeloproliferative neoplasm Arterial disorder Cardiac failure Univentricular heart Epicondylitis Hereditary ataxia Thyroid mass Endometrial cancer stage IV Angiosarcoma metastatic Peripheral artery angioplasty Lung adenocarcinoma stage III Eclampsia Tachypnoea Polycythaemia vera More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study Comparing Dalbavancin to Standard Antibiotics for Patients with Staphylococcus aureus Bloodstream Infections

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Staphylococcal infection
    Investigated Drugs:
    • Ambroxol Hydrochloride
    • CEFTAROLINE FOSAMIL
    • Clindamycin Hydrochloride
    France

  • Study on Cluster Headache Using Befiradol (18F) for Patients with Episodic Symptoms

    Recruiting

    2 1 1
    Investigated Diseases:
    • Cluster headache
    Investigated Drugs:
    • Befiradol (18F)
    France

  • Study on Duloxetine and Benztropine Mesylate for Patients with Severe Functional Somatic Disorder

    Recruiting

    3 1 1
    Investigated Diseases:
    • Somatic symptom disorder
    Investigated Drugs:
    • Benztropine Mesylate
    • Duloxetine
    Denmark

  • Study on Intra-Arterial Thrombolysis with Alteplase for Patients with Acute Ischemic Stroke in the Anterior Circulation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Alteplase
    France

  • Prevention of Infantile Spasms with Vigabatrin in High-Risk Children Under 1 Year Old: A Study for Patients with Tuberous Sclerosis or Large Vascular Brain Injury

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Infantile spasms
    Investigated Drugs:
    • Vigabatrin
    Finland

  • Study on the Use of Hyperpolarized Pyruvate for MRI Scans in Patients with Pancreatic Cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    Investigated Drugs:
    • Pyruvic Acid
    Denmark
Previous Page
1 … 366 367 368 369 370 … 1,650
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!